Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

Title
Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 16, Issue 19, Pages 4769-4778
Publisher
American Association for Cancer Research (AACR)
Online
2010-08-31
DOI
10.1158/1078-0432.ccr-10-0987

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now